Terenz Company

Terenz simplifies the diagnosis of Neurodegenerative Diseases by leveraging Artifiical Intelligence .

Last Funding Type: Seed
Funding Status: Seed
Headquarters: Busan, Pusan-jikhalsi, South Korea
Founded Date: 2019-03-06
Last Funding Date: 2021-03-01
Employee Number: 1-10
Estimated Revenue: $1M to $10M
Industry: Neurodegeneration and Aging